Reference health
Nanotheranostics: Congo Red/Rutin‐MNPs with Enhanced Magnetic Resonance Imaging and H<sub>2</sub>O<sub>2</sub>‐Responsive Therapy of Alzheimer's Disease in APPswe/PS1dE9 Transgenic Mice
49/49 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 49 checked references that resolve
resolves10.1016/S1474-4422(14)70090-0
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
resolves10.1021/nn4058215
Lipoprotein-Based Nanoparticles Rescue the Memory Loss of Mice with Alzheimer’s Disease by Accelerating the Clearance of Amyloid-Beta
resolves10.1002/adhm.201200067
Mesoporous Silica Nanoparticle‐based H<sub>2</sub>O<sub>2</sub> Responsive Controlled‐Release System Used for Alzheimer's Disease Treatment
resolves10.1002/adfm.201301015
Gold Nanocage‐Based Dual Responsive “Caged Metal Chelator” Release System: Noninvasive Remote Control with Near Infrared for Potential Treatment of Alzheimer's Disease
resolves10.1039/c000254b
A novel profluorescent probe for detecting oxidative stress induced by metal and H2O2 in living cells
resolves10.1016/j.biomaterials.2014.12.005
Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI)
resolves10.1016/j.biomaterials.2013.02.003
Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration
resolves10.1016/j.neuroimage.2011.01.023
Detection of amyloid plaques targeted by USPIO-Aβ1–42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging
resolves10.4155/tde.11.21
Design and Evaluation of Chitosan Nanoparticles As Novel Drug Carrier for the Delivery of Rivastigmine to Treat Alzheimer‘s Disease
resolves10.1002/adma.201304744
Anchoring Group Effects of Surface Ligands on Magnetic Properties of Fe<sub>3</sub>O<sub>4</sub> Nanoparticles: Towards High Performance MRI Contrast Agents
resolves10.1002/adma.200602326
A High‐Performance Magnetic Resonance Imaging <i>T</i><sub>2</sub> Contrast Agent
resolves10.1002/adma.201401124
Core–Shell‐Type Magnetic Mesoporous Silica Nanocomposites for Bioimaging and Therapeutic Agent Delivery
resolves10.1002/adma.201101401
Multiplexed Magnetic Labeling Amplification Using Oligonucleotide Hybridization
resolves10.1039/C4TB00085D
A rheumatoid arthritis magnetic resonance imaging contrast agent based on folic acid conjugated PEG-b-PAA@SPION
resolves10.1155/2011/615829
The Blood-Brain Barrier and Microvascular Water Exchange in Alzheimer's Disease
resolves10.1038/jcbfm.2009.192
Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review
resolves10.1371/journal.pone.0057097
Detection of Amyloid Plaques Targeted by Bifunctional USPIO in Alzheimer’s Disease Transgenic Mice Using Magnetic Resonance Microimaging
resolves10.3233/JAD-121171
SPION-Enhanced Magnetic Resonance Imaging of Alzheimer's Disease Plaques in AβPP/PS-1 Transgenic Mouse Brain
resolves10.1038/nnano.2014.254
Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease
resolves10.1097/WNR.0b013e32835ba850
Magnetic resonance imaging of amyloid plaques using hollow manganese oxide nanoparticles conjugated with antibody aβ1–40 in a transgenic mouse model
resolves10.1002/ar.21209
Detection of Aβ Plaques by a Novel Specific MRI Probe Precursor CR‐BSA‐(Gd‐DTPA)<i>n</i> in APP/PS1 Transgenic Mice
resolves10.1002/adfm.201400256
Ultrasmall Confined Iron Oxide Nanoparticle MSNs as a pH‐Responsive Theranostic Platform
resolves10.1016/S1074-5521(96)90118-0
Amyloid probes based on Congo Red distinguish between fibrils comprising different peptides
resolves10.1093/jnen/61.9.797
Imaging Aβ Plaques in Living Transgenic Mice with Multiphoton Microscopy and Methoxy-X04, a Systemically Administered Congo Red Derivative
resolves10.3233/JAD-131031
Optical and SPION-Enhanced MR Imaging Shows that trans-Stilbene Inhibitors of NF-κB Concomitantly Lower Alzheimer's Disease Plaque Formation and Microglial Activation in AβPP/PS-1 Transgenic Mouse Brain
resolves10.1039/c3sc50697e
Cerium oxide caged metal chelator: anti-aggregation and anti-oxidation integrated H2O2-responsive controlled drug release for potential Alzheimer's disease treatment
resolves10.1021/ja110468v
A Biocompatible Oxidation-Triggered Carrier Polymer with Potential in Therapeutics
resolves10.1016/j.neuro.2012.03.003
Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines
resolves10.1016/j.bbr.2014.02.002
Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation
resolves10.1016/j.jconrel.2011.03.014
Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes
resolves10.1016/j.biomaterials.2013.07.007
Indocyanine green loaded SPIO nanoparticles with phospholipid-PEG coating for dual-modal imaging and photothermal therapy
resolves10.1002/adma.201203169
A Synergistically Enhanced <i>T</i><sub>1</sub>–<i>T</i><sub>2</sub> Dual‐Modal Contrast Agent
resolves10.1039/C4NR05781C
Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging
resolves10.1016/j.colsurfb.2014.04.027
Effect of PEG molecular weight on stability, T2 contrast, cytotoxicity, and cellular uptake of superparamagnetic iron oxide nanoparticles (SPIONs)
resolves10.1016/j.colsurfa.2014.01.043
PEGylation of surfacted magnetite core–shell nanoparticles for biomedical application
resolves10.1021/la901776a
Glucose-Responsive Micelles from Self-Assembly of Poly(ethylene glycol)-<i>b</i>-Poly(acrylic acid-<i>co</i>-acrylamidophenylboronic acid) and the Controlled Release of Insulin
resolves10.1016/j.neulet.2010.07.067
Protective effect of (−)clausenamide against Aβ-induced neurotoxicity in differentiated PC12 cells
resolves10.1016/j.addr.2006.09.013
Recent advances in iron oxide nanocrystal technology for medical imaging☆
resolves10.1148/radiology.175.2.2326474
Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.
resolves10.1097/01.rli.0000129472.45832.b0
Phase I Clinical Evaluation of Citrate-coated Monocrystalline Very Small Superparamagnetic Iron Oxide Particles as a New Contrast Medium for Magnetic Resonance Imaging
The 2 references without a DOI — listed, not checked
no DOI — not checkede_1_2_3_17_1
no DOI — not checkede_1_2_3_19_2
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1002/adma.201502227"><img src="https://citestamp.com/citestamped/10.1002/adma.201502227/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1002/adma.201502227)